CONTINEUM THERAPEUTICS INC-A (CTNM) Stock Analyst Ratings
NASDAQ:CTNM - Nasdaq - US21217B1008 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 86% to CTNM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 29.84. This target is 340.69% above the current price.
CTNM was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CTNM.
In the previous month the buy percentage consensus was at a similar level.
CTNM was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-07 | Baird | Maintains | Outperform -> Outperform |
| 2025-01-09 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-22 | Baird | Initiate | Outperform |
| 2024-08-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-04-30 | RBC Capital | Initiate | Outperform |
| 2024-04-30 | Stifel | Initiate | Buy |
| 2024-04-30 | Morgan Stanley | Initiate | Overweight |